Biotech

Big Pharma’s $13.7B Alzheimer’s Drug Market Has a Progress Problem: Here Are Three Small-Cap Biotech Stocks That Could Disrupt the Market

Alzheimer’s Drug Market Faces Urgent Need for Innovative Therapies Beyond Big Pharma These Small-Cap Biotech Stocks Lead the Charge with…

Read More »

Therma Bright’s Investment Company InStatin Signs Discovery Study Agreement With Mountain West Research

Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX), a developer and investment partner in cutting-edge diagnostic and medical device technologies,…

Read More »

$20M Healthcare Stock Breaks Out After Rising 1,700% on Medicare and Medicaid Clearance, Here’s What’s Being Announced in the Coming Months in a 25X Larger Market

Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX), a burgeoning name in the medical device industry, has achieved a significant…

Read More »

Therma Bright Adds Experienced Pharma and Medical Device Industry Veteran to Advisory Board

Therma Bright (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX), a developer and investment partner in advanced diagnostic and medical device technologies,…

Read More »

Tempest Therapeutics (TPST) Stock Jumps 83% on FDA Phase 3 Trial News

Tempest Therapeutics (NASDAQ: TPST), a clinical-stage biotechnology firm focused on innovative cancer therapies, announced a significant milestone on Thursday as…

Read More »

Sangamo Therapeutics Inks $1.95B Deal With Genentech to Target Alzheimer’s, SGMO Stock Pops 29%

In a significant advancement for the field of genomic medicine, Sangamo Therapeutics has entered a landmark license agreement with Genentech,…

Read More »

Altimmune (ALT) Stock Soars 27%: Phase 2 Data on Obesity Drug Ignites Market Optimism

In a remarkable turn of events, Altimmune (NASDAQ: ALT) witnessed a staggering 27% surge in its stock price this morning,…

Read More »

Gilead Sciences (GILD) Stock Surges 4% on Positive Drug Trials and Promising Obesity and Weight Loss Treatments

Gilead Sciences (NASDAQ: GILD) witnessed a notable 4% surge in its stock price this morning, driven by a confluence of…

Read More »

Day One Biopharmaceuticals (DAWN) Stock Soars 11.3% on Strategic Milestones and Promising Outlook

Shares of Day One Biopharmaceuticals (NASDAQ: DAWN) surged 11.3% this morning, reflecting strong investor confidence fueled by a series of…

Read More »

Intra-Cellular Therapies (NASDAQ: ITCI): A Comprehensive Analysis

Company Overview Intra-Cellular Therapies (NASDAQ: ITCI) is a biopharmaceutical company focused on the development of therapeutics for central nervous system…

Read More »
Back to top button